Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Sarcoma 1Genitourinary 1

Conditions

Breast Neoplasms 14Prostatic Neoplasms 12Multiple Myeloma 8Neoplasm Metastasis 6Osteoporosis 4Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Ovarian Neoplasms 2Neoplasms, Plasma Cell 2Lung Neoplasms 2Kidney Neoplasms 2Bone Diseases 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Osteonecrosis 1Oligodendroglioma 1Neovascularization, Pathologic 1Neoplasms by Site 1Neoplasms 1Neoplasm, Residual 1Neoplasm Micrometastasis 1Nasopharyngeal Neoplasms 1Myelodysplastic Syndromes 1Mesothelioma 1Lymphoma 1

Interventions

Zoledronic Acid 2saracatinib 1odanacatib 1etelcalcetide hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Bone Diseases × Zoledronic Acid × Clear all
NCT00399802 2018-08-16

A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)

Merck Sharp & Dohme LLC

Phase 2 Completed
43 enrolled 10 charts
Breast

Bone Diseases, Breast Neoplasms

NCT00558272 2013-05-27

Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease

AstraZeneca

Phase 2 Completed
139 enrolled 23 charts
BreastGenitourinarySarcoma

Bone Diseases, Bone Neoplasms, Breast Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡